Navigation Links
NeurogesX Reports First Quarter 2011 Results
Date:4/29/2011

53NEUROGESX, INC. Condensed Consolidated Balance Sheets (in thousands) March 31,2011December 31,2010Assets(Note 1)Current assets:Cash and cash equivalents

$
4,240

$
8,705Short-term investments

30,463

38,125Trade receivable

623

607Receivable from collaboration partner

98

65Inventories

768

786Prepaid expenses and other current assets

1,770

1,082Restricted cash

290

290Total current assets

38,252

49,660Property and equipment, net

774

809Restricted cash

120

120Other assets

253

261Total assets

$
39,399

$
50,850Liabilities and Stockholders' DeficitCurrent liabilities:Accounts payable

$  1,674

$  1,544Accrued compensation

1,506

1,867Accrued research and development

821

582Other accrued expenses

4,173

3,011Deferred product revenue, net

563

577Deferred collaboration revenue

7,261

7,242Long term obligations—current portion

2,605

2,222Total current liabilities

18,603

17,045Non-current liabilities:Deferred collaboration revenue

30,554

32,359Deferred rent

67

115Long term obligations

44,230

42,622Total non-current liabilities

74,851

75,096Commitments and contingencies Stockholders' deficit:Common stock, $0.001 par value

18

18Additional paidin capital

215,806

215,220Accumulated other comprehensive gain (loss)

11

(2)Accumulated deficit

(269,890)

(256,527)Total stockholders' deficit

(54,055)

(41,291)Total liabilities and stockholders' deficit

$  39,399

$  50,850(Note 1) Derived from the audited consolidated financial statements as of December 31, 2010.NeurogesX, Inc.Stephen Ghiglieri

Executive Vice President, COO


'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. NeurogesX Receives Notice of Allowance for Patent Covering NGX-1998 Capsaicin Topical Liquid
2. NeurogesX Reports Fourth Quarter and Year-End 2010 Results
3. NeurogesX to Provide Qutenza® Launch Update
4. NeurogesX to Present at Two February Investor Conferences
5. NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
6. NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation
7. NeurogesX to Hold Conference Call to Discuss Third Quarter 2010 Results
8. NeurogesX to Present at Oppenheimer & Co Healthcare Conference
9. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
10. NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
11. NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") ... its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for ... Solta Medical, Inc. (NASDAQ: SLTM ) ("Solta") ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... Corporation (Nasdaq: LMNX ) today announced that it ... on Monday, February 3, 2014. A press release announcing the ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management ... and financial results for the fourth quarter and twelve months ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
(Date:4/24/2014)... An Oregon State University researcher has found a relationship ... symptoms of autism spectrum disorder in very young children. ... first to show a direct relationship between motor skills ... gross motor skills should be included in treatment plans ... assistant professor in OSU,s College of Public Health and ...
(Date:4/24/2014)... caused the first flu pandemic in the 21st century. ... more than 50 people in the country. Since 2011 ... (winter/spring seasons). , Infections with influenza pH1N1 virus ... Organization has recommended Tamiflu for treatment of patients with ... is that it targets viral proteins which mutate quickly ...
(Date:4/23/2014)... Hospital (MGH) investigators may lead to greater availability and ... problem use of fecal material from healthy donors ... difficile ( C. difficile ) bacteria. In ... Clinical Infectious Diseases , the researchers report that use ... patients was as successful in curing recurrent C. ...
(Date:4/23/2014)... April 24, 2014 Pregnant immigrants from Sub-Saharan ... increased monitoring during pregnancy, according to new research ... today in the British Journal of Obstetrics ... and eclampsia rates among immigrants and native-born women ... (Ontario), Denmark, Sweden, Spain (Catalonia and Valencia) and ...
(Date:4/23/2014)... Spokane have developed a new way to detect ... the wheel. , Their recently patented technology is ... in drowsy driversand offers an affordable and more ... detection systems. , Van Dongen"Video-based systems that use ... out of its lane are cumbersome and expensive," ...
Breaking Medicine News(10 mins):Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:Pregnancy complications may be more common in immigrants from certain regions 2Health News:WSU innovation improves drowsy driver detection 2
... Ben Cousins broke his silence for the first time. Since his ... has indeed a problem of substance abuse. ,He revealed ... the past months. He was being treated for a number of ... did not disclose the name of the drug that he had ...
... a doc, there is a woman; much like the association between a ... ,Some Older men need to be goaded to see a doctor, ... could be a wife, daughter or even a female friend. ... years visit a doctor only after being coaxed and cajoled into seeing ...
... of the public health system in the US keeps tumbling out ... adults with serious mental illness and treated in public systems ... gap has widened since the early '90s when major mental disorders ... going in the wrong direction and have to change course," says ...
... the bottle is not funny. Infact their love for the ... overburdened by the fallout of the binge drinking culture ... become a trend evident among all age groups, class, boundaries ... doom for Australia in the next 20 years. Many Australians ...
... easy access to alcohol-based handrubs can improve hygiene in ... Access journal Critical Care suggests. ,Good ... the spread of infections within hospitals. Alcohol-based handrubs are ... amongst hospital staff remains low. ,One of ...
... a long period of time may decrease brain volume, according ... of Neurology's 59th Annual Meeting in Boston, April 28 ... scans of 1,839 people from the Framingham Offspring study, ages ... low drinkers (one to seven drinks per week), moderate drinkers ...
Cached Medicine News:Health News:Cousins Recovering from His Substance Abuse Problem 2Health News:Major Mental Disorders Cut Life Span by Ten to Fifteen Years 2Health News:Drinking Heavy Amounts of Alcohol Shrinks Your Brain 2
MBP's equivalent to the "Universal Yellow" tip, this 200 L tip utilizes a MicroPoint design for accurate sample handling. 10 L Ref. mark....
... an immunometric ('sandwich') EIA for the ... serum or plasma. LH in the ... anti-LH antibodies directed at different epitopes. ... particles and the other is labelled ...
... is a glycoprotein secreted by the anterior ... TSH, the intact LH molecule is a ... glycoproteins all have homologous alpha-subunits, however each ... and FSH production and secretion are stimulated ...
Microwell-EIA for the detection of GAD Autoantibody....
Medicine Products: